Arkolith/Insider Trading/APUS/Form 4

Emerson Erik C.

Chief Executive Officer, DirectorApimeds Pharmaceuticals US, Inc. (APUS) · full profile →Form 4 · filed Oct 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2025Grant(A)215K—$0215K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001710496-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML